Candidate Information Title Management Director Account Manager Target Location US-NJ-Secaucus Email Available with paid plan Phone Available with paid plan	20,000+ Fresh Resumes Monthly     View Phone Numbers     Receive Resume E-mail Alerts     Post Jobs Free     Link your Free Jobs Page     ... and much more Register on Jobvertise Free
Search 2 million Resumes Keywords: City or Zip:	Related Resumes

Freelance Account ManagerPrivate Practice, September Street Address  to PresentAvailable for account work on short-term bases. Develop points-of-views and tactical plans. Manage execution of tactical plans. Financial management and resource allocation.VP, Management Director/NeonNeon/August Street Address September 2022Preparing Libtayo, an immuno-oncology agent, for a new indication launch both in the US and Global. Primarily HCP focus. Leading patient strategy development.(Originally joined as Freelance Account Manager and made permanent staff in January 2021.)SVP, Management SupervisorMHNJ/July 2019February 2020Led the US and Global launches for novel closed and open loop systems for the personalized management of Type 1 and Type 2 diabetes.Responsible for overseeing and providing strategic guidance, developing integrated marketing plans, scopes-of-work, developing and executing agency KPIs, financial goals, staffing, and mentoring staff.Drives alignment across US and Global as well as patient and professional client teams.Manages eight-person Account team with indirect management responsibility for Strategy and Creative output.Integrates new processes to improve quality and efficiencies.SVP, Director of Agency ExcellenceWildType Health, February 2016July 2019Distinct position developed to meet the unique needs of the KEYTRUDA (Merck/Oncology) business. Primary responsibilities are driving consistency across indications, reducing duplication of efforts, and guiding compliance with Merck process and procedures.Tracked quantitative and qualitative metrics to monitor the success of project submissions as a proxy for agency performance. Reversed the number of rejections the Agency experienced to eliminate non-billable hours incurred fixing mistakes.Worked with Client leaders on change management to reduce churn by fostering consistency across PRT teams and enforcing productive Client behavior.Partnered with other departments, chiefly Account and Finance, to develop persuasive presentations and points-of-view aimed primarily at change management.Provided training to new hires including Introduction to 220, Drug Development, and Understanding Accelerated Approval.When it comes to delivering the highest-caliber, high-profile, multi-channel campaigns, Judith brings experience that spans disease categories, communication channels, and audiences. Judith has led numerous US and global product launches and has frequently managed the hub for larger brand assignments. In these roles, she was responsible for approving content for partner agencies and managing work streams for relevant brand disciplines such as medical education, managed markets and third-party vendors.BACHELOR OF ARTSHuman Communications & JournalismDouglass College atRutgers UniversityJUDITH BRITTONAccountabilityAttention to DetailBudget ManagementTeam LeadershipLaunch PlanningImproving EfficiencyRisk AssessmentResource ManagementSVP, Management SupervisorPHONE NUMBER AVAILABLEPROFESSIONAL PROFILEEXPERIENCEEMAIL AVAILABLESecaucus, NJLINKEDIN LINK AVAILABLEjudith-britton-9a02995/SKILLSEDUCATIONMicrosoft Office SuiteCONTRIBUTING KNITTERSpecial OlympicsCONTRIBUTING KNITTERChemo Caps and LapghansMONTHLY PATRONSt. Judes Childrens HospitalMONTHLY PATRONASPCA of AmericaEXTRASVP, Management SupervisorWildtype Health/August 2014February 2016Led the successful, ground-breaking launch of the metastatic melanoma indication and the prelaunch work for the metastatic lung indication for KEYTRUDA, the first PD-L1 immunotherapy launched in the US market.Led the development of messaging transition from the concept of PD-L1 inhibition to primary focus on the brandoAlso led development of messages for 1L melanoma indicationContributed to the increase in fee from $12MM to $24MM year 2 to year 3.Exercised marketing expertise including market and patient analysis, brand positioning, promotional channel strategy to reach 100% of target audience in 30 days in the US and for global market through headquarter programs.Partnered with Clients to develop marketing and promotional presentations to management.Managed the Franchise Week brand book development across all indications.SVP, Management SupervisorArea 23/September 2012August 2014Global Brand Champion for Jardiance, a SGLT-2 inhibitor for Type 2 Diabetes; joint venture between Boehringer-Ingelheim and Lilly.Managed multiple clients across both organizations to gain alignment and approval of messages and creative concept.Championed development of prelaunch campaign.Created opportunities for affiliate agencies.Organic growth achieved with award of the combination product.SVP, Management SupervisorNeON September 2008September 2012Managed the Boehringer-Ingelheim Micardis franchise.Launched the cardiovascular indication for Micardis.Generated organic growth with award of the combination business.Initiated a fully online professional and patient program that increase NRx share by 1%.JUDITH BRITTONSVP, Management SupervisorPHONE NUMBER AVAILABLEEXPERIENCE continuedEMAIL AVAILABLESecaucus, NJLINKEDIN LINK AVAILABLEjudith-britton-9a02995/TECHNICAL SKILLSSVP, Management SupervisorRegan Campbell Ward, June 2003September 2009Managed multiple businesses ranging from dermatology and womens contraceptives to Nexavar, a tumor growth inhibitor indicated for RCC and HCC and an anti-fungal indicated for hospital- acquired infections.Drove new business pitches which resulted in multiple wins:oAvandia franchise from GSKoNovartis rebrand of Zometa for Pagets Disease of the Bone and postmenopausal osteoporosisoNovartis vildagliptin, a DPP-4 inhibitor for Type 2 Diabetes.SVP, Management SupervisorRobert A. Becker/November 2001June 2003Managed Peg-Intron for HCV indication (Schering), Levitra for erectile dysfunction (Bayer/GSK), and Ditropan XL for bladder dysfunction in women (Ortho).Managed prelaunch and launch planning for Pravagard, a combination of Pravachol and aspirin (BMS).SVP, Group Account DirectorMedicus/June 1998November 2001Launched Atacand (AstraZeneca/hypertension).Oversaw management of Serono ad Quest Diagnostics.Pitched and won LaserSight Technologies excimer laser and microkeratome systems.Pitched and won Aggrastat a platelet inhibitor (Merck/unstable angina & NSTEMI).VP, Group Account SupervisorCline, Davis & Mann/ May 1997June 1998Responsible for Pepcid (Merck/GERD) and Aggrastat (Merck/unstable angina & NSTEMI).SVP, Management SupervisorBEVERLY PIZARCZYKDirect Report at WildTypeEMAIL AVAILABLESCOTT ROBBINSCreative Partner at LM&P, CDM, RCW, and WildTypeEMAIL AVAILABLEJUDY KIDESFinance Partner at WildTypeEMAIL AVAILABLEMARGARET SARAH ALEXANDERBoehringer-IngelheimClient at NeONPHONE NUMBER AVAILABLEBELL LEADERSHIP PROGRAM2019HBA RISING STARHealthcare Businesswomens AssociationPROFESSIONAL DEVELOPMENTJUDITH BRITTONPHONE NUMBER AVAILABLEEXPERIENCE continuedEMAIL AVAILABLESecaucus, NJLINKEDIN LINK AVAILABLEjudith-britton-9a02995/REFERENCES